NCT03515213View on ClinicalTrials.gov

Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 27, 2017

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Huntington Disease
Interventions
DRUG

Fenofibrate

145mg of fenofibrate

DRUG

Placebo

Placebo

Trial Locations (1)

92697

University of California, Irvine, Irvine

All Listed Sponsors
lead

University of California, Irvine

OTHER

NCT03515213 - Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease | Biotech Hunter | Biotech Hunter